Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4LZK
|
||||
| Drug Name |
(1S,2S)-2-bromo-7-oxa-5-aza-bicyclo[3.2.1]octan-6-one
|
||||
| Synonyms |
CHEMBL397972
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C6H8BrNO2
|
||||
| Canonical SMILES |
Br[C@H]1CCN2C[C@@H]1OC2=O
|
||||
| InChI |
InChI=1S/C6H8BrNO2/c7-4-1-2-8-3-5(4)10-6(8)9/h4-5H,1-3H2/t4-,5-/m0/s1
|
||||
| InChIKey |
VVSXVRNUMNINTL-WHFBIAKZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.